Page 17«..10..16171819..3040..»

BU Researchers Helped Develop the First FDA-Approved Gene Therapies to Treat Sickle Cell Disease – Boston University

BU Researchers Helped Develop the First FDA-Approved Gene Therapies to Treat Sickle Cell Disease  Boston University

Read the original post:
BU Researchers Helped Develop the First FDA-Approved Gene Therapies to Treat Sickle Cell Disease - Boston University

Recommendation and review posted by Bethany Smith

Cell- and gene-therapy hub bound for Lake Success; New York to invest up to $150 million – Newsday

Cell- and gene-therapy hub bound for Lake Success; New York to invest up to $150 million  Newsday

Go here to see the original:
Cell- and gene-therapy hub bound for Lake Success; New York to invest up to $150 million - Newsday

Recommendation and review posted by Bethany Smith

Research discovers that mice possess a natural gene therapy system – Phys.org

Research discovers that mice possess a natural gene therapy system  Phys.org

Go here to see the original:
Research discovers that mice possess a natural gene therapy system - Phys.org

Recommendation and review posted by Bethany Smith

On Long Island, a request for proposals for a cell and gene therapy hub – Long Island Business News

On Long Island, a request for proposals for a cell and gene therapy hub  Long Island Business News

Continued here:
On Long Island, a request for proposals for a cell and gene therapy hub - Long Island Business News

Recommendation and review posted by Bethany Smith

Gene therapy curbs hard-to-treat form of epilepsy in mice – FierceBiotech

Gene therapy curbs hard-to-treat form of epilepsy in mice  FierceBiotech

Read the original:
Gene therapy curbs hard-to-treat form of epilepsy in mice - FierceBiotech

Recommendation and review posted by Bethany Smith

Rett patients receive a new gene therapy treatment at Texas Children’s Hospital and Baylor College of Medicine – Baylor College of Medicine

Rett patients receive a new gene therapy treatment at Texas Children's Hospital and Baylor College of Medicine  Baylor College of Medicine

Read the original here:
Rett patients receive a new gene therapy treatment at Texas Children's Hospital and Baylor College of Medicine - Baylor College of Medicine

Recommendation and review posted by Bethany Smith

Mice have innate gene therapy agent to sidestep mutations, study finds – New Atlas

Mice have innate gene therapy agent to sidestep mutations, study finds  New Atlas

View original post here:
Mice have innate gene therapy agent to sidestep mutations, study finds - New Atlas

Recommendation and review posted by Bethany Smith

Opinion | A Closer Look at the Approval of CRISPR/Cas9 Gene Therapy for Sickle Cell Disease – Medpage Today

Opinion | A Closer Look at the Approval of CRISPR/Cas9 Gene Therapy for Sickle Cell Disease  Medpage Today

Visit link:
Opinion | A Closer Look at the Approval of CRISPR/Cas9 Gene Therapy for Sickle Cell Disease - Medpage Today

Recommendation and review posted by Bethany Smith

ASH Gene Therapy Highlights in Hemophilia, TDT: Vertex Pharmaceuticals, CSL Behring, and More – Precision Medicine Online

ASH Gene Therapy Highlights in Hemophilia, TDT: Vertex Pharmaceuticals, CSL Behring, and More  Precision Medicine Online

Read more here:
ASH Gene Therapy Highlights in Hemophilia, TDT: Vertex Pharmaceuticals, CSL Behring, and More - Precision Medicine Online

Recommendation and review posted by Bethany Smith

FDA Approves First Gene Therapies for Treatment in Patients With Sickle Cell Disease – Drug Topics

FDA Approves First Gene Therapies for Treatment in Patients With Sickle Cell Disease  Drug Topics

Read the original post:
FDA Approves First Gene Therapies for Treatment in Patients With Sickle Cell Disease - Drug Topics

Recommendation and review posted by Bethany Smith

Research Reveals Opportunities to Better Address Blood Disorders Early in Life – Cancer Health Treatment News

Research Reveals Opportunities to Better Address Blood Disorders Early in Life  Cancer Health Treatment News

Read the rest here:
Research Reveals Opportunities to Better Address Blood Disorders Early in Life - Cancer Health Treatment News

Recommendation and review posted by Bethany Smith

Were turning aging research into a therapeutic category – Longevity.Technology

Were turning aging research into a therapeutic category  Longevity.Technology

View post:
Were turning aging research into a therapeutic category - Longevity.Technology

Recommendation and review posted by Bethany Smith

University of Pennsylvania Gene Therapy Program cuts staff by 25%, report says – The Business Journals

University of Pennsylvania Gene Therapy Program cuts staff by 25%, report says  The Business Journals

Originally posted here:
University of Pennsylvania Gene Therapy Program cuts staff by 25%, report says - The Business Journals

Recommendation and review posted by Bethany Smith

Space-Age Alzheimer’s Test, Gene Therapy Delivery Get Boost – Mirage News

Space-Age Alzheimer's Test, Gene Therapy Delivery Get Boost  Mirage News

Originally posted here:
Space-Age Alzheimer's Test, Gene Therapy Delivery Get Boost - Mirage News

Recommendation and review posted by Bethany Smith

ASTCT Response to FDA Approval of Gene Therapies for Treatment of Sickle Cell Disease (SCD) – Newswire

ASTCT Response to FDA Approval of Gene Therapies for Treatment of Sickle Cell Disease (SCD)  Newswire

Follow this link:
ASTCT Response to FDA Approval of Gene Therapies for Treatment of Sickle Cell Disease (SCD) - Newswire

Recommendation and review posted by Bethany Smith

Cancer Gene Therapy Industry Envisions a Valuation of US$ 5.3 Billion by 2032-FMI Projection – PharmiWeb.com

Cancer Gene Therapy Industry Envisions a Valuation of US$ 5.3 Billion by 2032-FMI Projection  PharmiWeb.com

Continue reading here:
Cancer Gene Therapy Industry Envisions a Valuation of US$ 5.3 Billion by 2032-FMI Projection - PharmiWeb.com

Recommendation and review posted by Bethany Smith

Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute … – PR Newswire

Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute ...  PR Newswire

Continued here:
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute ... - PR Newswire

Recommendation and review posted by Bethany Smith

Research Reveals Opportunities to Better Address Blood Disorders Early in Life – Yahoo Finance

Research Reveals Opportunities to Better Address Blood Disorders Early in Life  Yahoo Finance

See more here:
Research Reveals Opportunities to Better Address Blood Disorders Early in Life - Yahoo Finance

Recommendation and review posted by Bethany Smith

Male Hypogonadism Market Expected to Reach $5.1 Billion by 2030 | Current Trends and Industry Analysis – EIN News

Male Hypogonadism Market Expected to Reach $5.1 Billion by 2030 | Current Trends and Industry Analysis  EIN News

Originally posted here:
Male Hypogonadism Market Expected to Reach $5.1 Billion by 2030 | Current Trends and Industry Analysis - EIN News

Recommendation and review posted by Bethany Smith

Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform – PR Newswire

Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform  PR Newswire

Read the rest here:
Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform - PR Newswire

Recommendation and review posted by Bethany Smith

Improvements in Stem Cell Transplants for AML With CRISPR – Targeted Oncology

Improvements in Stem Cell Transplants for AML With CRISPR  Targeted Oncology

Read this article:
Improvements in Stem Cell Transplants for AML With CRISPR - Targeted Oncology

Recommendation and review posted by Bethany Smith

Breakthrough Gene Therapies for Sickle Cell Disease Approved by FDA – Medriva

Breakthrough Gene Therapies for Sickle Cell Disease Approved by FDA  Medriva

Read the original post:
Breakthrough Gene Therapies for Sickle Cell Disease Approved by FDA - Medriva

Recommendation and review posted by Bethany Smith

Home – CHS Hormone

Stephanie is professional, personable, and a joy to be around. She puts you right at ease. Explains all procedures. She is very knowledgeable in all aspects of her profession.

(Injectable and hormone patient TS from Awendaw)

I really bonded with Stephanie! She explained things so well. I am looking forward to seeing her again

(Hormone patient- MS from James Island)

Stephanies the best!

(hormone and injectable patient BR from Mount Pleasant)

Stephanie is a life changer! I know my body well, and going through changes she makes me feel like I am not loosing my mind. Going to my regular OB doctor in regards to hormonal issues I have been told that what I am going through is not pre- menopausal. Wrong!!! Stephanie has me set up on hormone replacement therapy that has been a game changer. I feel great, I have a ton of energy and I most importantly I feel balanced all day long. Her knowledge and expertise is top notch! I highly recommend her. Not only is she knowledgeable, she goes the extra mile to explain things, she also gives you options to what you as a patient are comfortable with. I love that she supports the route (you as a patient) decides to do. I highly recommend Stephanie at Charleston Hormone Replacement and Aesthetic Services.

Hormone Patient

Stephanie Donovan is the absolute best at what she does. She takes her time to review your labs and to talk about any aesthetic procedures in detail so that you feel completely comfortable with what your goal is. Shes knowledgeable about the latest technology and knows how to customize the right solution just for you. I trust my face, lips, and everything with her!

Hormone Patient

Stephanie is amazing! Love the new office. She has helped me improve my quality of life so much I cant even explain how good I feel all the time now. Super friendly, professional, and always caring and super helpful. Cant recommend her enough!

Hormone Patient

Stephanie is amazing at what she does! She has changed my life with educating me on the importance of hormone therapy and has provided excellent care. She has a heart for what she does and truly cares about her patients.

Hormone Patient

Cannot say enough good things about my experience with Stephanie! She thoroughly takes the time to listen and care for her patients. The best in Charleston for injectables and hormones!

Hormone and Cosmetic Patient

So happy I finally found Steph again!!! She is the BEST in Charleston. Definitely give her a try for all your aesthetic needs as well womens health!! Hormone guru!!! Highly recommend !!!!

Aesthetic patient from Isle of Palms, SC

Everyone should get their levels checked at one or more points in life to optimize our health and general feeling of wellness and this is a great place to do it! The initial consult was very attentive and detailed. Stephanie spent a lot of time explaining my results so that I felt confident in the drivers of my symptoms and next steps I needed to take. Definitely recommend. 🙂

-Hormone Patient from Charleston, SC

I went today to have a pellet as Im visiting from out of town and it was time. I was nervous because it was my first time here and I wanted to make sure it would be pain-free. Stephanie was fantastic. Put my mind at ease. It was not painful at all and she was wonderful to deal with!

-Hormone Patient from Delray Beach, FL

See more here:
Home - CHS Hormone

Recommendation and review posted by Bethany Smith

My teenage son was indoctrinated by the trans cult from the classroom to the clinic: Mother left ‘grieving’ fo – Daily Mail

My teenage son was indoctrinated by the trans cult from the classroom to the clinic: Mother left 'grieving' fo  Daily Mail

Read more:
My teenage son was indoctrinated by the trans cult from the classroom to the clinic: Mother left 'grieving' fo - Daily Mail

Recommendation and review posted by Bethany Smith

Hypopituitarism – Hormonal and Metabolic Disorders – Merck Manuals …

Blood tests to measure hormone levels

An evaluation usually begins by measuring blood levels of the hormones that the pituitary gland produces (typically, thyroid-stimulating hormone, prolactin, luteinizing hormone, and follicle-stimulating hormone) and at the same time measuring levels of the hormone produced by the target organs (typically, thyroid hormone, testosterone in men, and estrogen in women).

For example, a person with hypothyroidism due to failure of the pituitary gland has low levels of thyroid hormone and low or inappropriately normal levels of thyroid-stimulating hormone, which is produced by the pituitary gland. In contrast, a person with hypothyroidism due to failure of the thyroid gland itself has low levels of thyroid hormone and high levels of thyroid-stimulating hormone.

Growth hormone production by the pituitary is difficult to evaluate because no single blood level accurately reflects it. The body usually produces growth hormone in several bursts a night, and the hormone is quickly used. Thus, the blood level at any given moment does not indicate whether production is normal over the course of a day. Instead, doctors measure the levels of insulin-like growth factor 1 (IGF-1) in the blood. Production of IGF-1 is controlled by growth hormone, and the level of IGF-1 tends to change slowly in proportion to the overall amount of growth hormone produced by the pituitary. In infants and young children, doctors may instead measure levels of a similar substance, IGF-binding protein type 3. Measurement of IGF-1 is not sufficient to make the diagnosis of growth hormone deficiency in adults, because people with normal levels may still have growth hormone deficiency. In many cases, a stimulation test to try to make the pituitary secrete growth hormone is used.

Because the levels of luteinizing hormone and follicle-stimulating hormone fluctuate with the menstrual cycle, their measurement in women may be difficult to interpret. However, in postmenopausal women who are not taking estrogen, luteinizing hormone and follicle-stimulating hormone levels normally are high. When they are found to be low, this can be an indication of pituitary damage or insufficiency of other hormones.

Production of ACTH is usually assessed by measuring the levels of its target hormone (cortisol) in response to stimuli, such as an injection of synthetic ACTH (ACTH stimulation test) or a low level of sugar in the blood after an insulin injection (insulin tolerance test). If the level of cortisol does not change and the level of ACTH in the blood is normal or low, a deficiency of ACTH production is confirmed.

Read more here:
Hypopituitarism - Hormonal and Metabolic Disorders - Merck Manuals ...

Recommendation and review posted by Bethany Smith


Archives